EP Wealth Advisors
TXG icon

EP Wealth Advisors’s 10x Genomics TXG Stock Holding History

EP Wealth Advisors’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$815K Sell
9,021
-8,369
-48% -$490K ﹤0.01% 766
2026
Q2 		$667K Sell
17,390
-617
-3% -$16.2K ﹤0.01% 901
2026
Q1 		$382K Buy
18,007
+6,501
+57% +$130K ﹤0.01% 1032
2025
Q4 		$188K Buy
+11,506
New +$174K ﹤0.01% 1401

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $17.4B AUM 41.01% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Quantinno Capital Management
Quantinno Capital Management New York $106B AUM 29.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

EP Wealth Advisors's TXG Position: Q3 2026 in Review

EP Wealth Advisors reduced its 10x Genomics (TXG) stake by 48% in Q3 2026, selling an estimated $490K and leaving 9,021 shares worth $815K. The position accounts for ﹤0.01% of the portfolio, ranked #766.

EP Wealth Advisors first reported a position in TXG in Q4 2025 and has held it in 4 quarters since. 377 funds tracked by Wall St. Rank hold TXG as of Q3 2026.

  • EP Wealth Advisors held 9,021 shares of 10x Genomics worth $815K as of Q3 2026.
  • EP Wealth Advisors sold 8,369 10x Genomics shares in Q3 2026, an estimated $490K.
  • 10x Genomics made up ﹤0.01% of EP Wealth Advisors's portfolio in Q3 2026, its #766 holding.
  • EP Wealth Advisors first reported a position in 10x Genomics in Q4 2025 and has held it in 4 quarters since.
  • 377 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.

Based on EP Wealth Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.